Cargando…
O10.6. OLANZAPINE IMPAIRS CENTRAL INSULIN ACTION: EFFECTS ON BODY FUEL PREFERENCE IN RATS
BACKGROUND: Antipsychotics (APs) remain the cornerstone of treatment in schizophrenia, with increasing use on- and off- label. Olanzapine (OLZ) is a highly prescribed, high metabolic liability AP. Olanzapine has also been found to shift major fuel preference from carbohydrates to fats (while impairi...
Autores principales: | Castellani, Laura, Wilkin, Jennifer, Ahsan, Zohra, Teo, Celine, Kowalchuk, Chantel, Giacca, Adria, Remington, Gary, Hahn, Margaret |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888319/ http://dx.doi.org/10.1093/schbul/sby015.258 |
Ejemplares similares
-
O9.2. ANTIPSYCHOTIC DRUGS IMPAIR BRAIN GLUCOSE SENSING RESULTING IN WHOLE BODY INSULIN RESISTANCE
por: Castellani, Laura, et al.
Publicado: (2020) -
F235. DIFFERENTIAL EFFECTS OF ANTIPSYCHOTICS ON NEUROINFLAMMATION AND ENERGY SENSING IN A HYPOTHALAMIC CELL LINE
por: Kowalchuk, Chantel, et al.
Publicado: (2018) -
Sodium Phenylbutyrate, a Drug With Known Capacity to Reduce Endoplasmic Reticulum Stress, Partially Alleviates Lipid-Induced Insulin Resistance and β-Cell Dysfunction in Humans
por: Xiao, Changting, et al.
Publicado: (2011) -
Amelioration of High-Insulin-Induced Skeletal Muscle Cell Insulin Resistance by Resveratrol Is Linked to Activation of AMPK and Restoration of GLUT4 Translocation
por: Vlavcheski, Filip, et al.
Publicado: (2020) -
Unraveling the Mechanisms Underlying Olanzapine-Induced Insulin Resistance
por: Irwin, Nigel, et al.
Publicado: (2013)